New SEC Form D filing
Dravite Therapeutics, Inc., 2026-09-03
A new SEC Form D private-offering notice from San Francisco, CA, a $52,999,992 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Dravite Therapeutics, Inc. Verified via SEC Form D
Filed 6 days agoFiled to raise $52,999,992First money in 2026-08-21Raised so far $52,999,992HQ (as filed) San Francisco, CASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Nuvve Holding Corp., 2026-09-04, $14.7M, San Diego, CA
- Pluri Inc., 2026-09-04, $3.7M, Haifa
- Gossamer Bio, Inc., 2026-09-04, $150M, San Diego, CA
- Superluminal Medicines, Inc., 2026-09-03, $65.5M, Boston, MA
- Tenon Medical, Inc., 2026-09-04, $3M, Los Gatos, CA
- Inventure, LLC, 2026-09-03, $82K, Southbury, CT
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.